The human papillomavirus type 16 (HPV-16) E6 and E7 oncogenes are thought to play a role in the development of most human cervical cancers. These E6 and E7 oncoproteins affect cell growth control at least in part through their association with and inactivation of the cellular tumor suppressor gene products, p53 and Rb. To study the biological activities of the HPV-16 E6 and E7 genes in epithelial cells in vivo, transgenic mice were generated in which expression of E6 and E7 was targeted to the ocular lens. Expression of the transgenes correlated with bilateral microphthalmia and cataracts (100%/ penetrance) resulting from an efficient impairment of lens fiber cell differentiation and coincident induction of cell proliferation. Lens tumors formed in 40% of adult mice from the mouse lineage with the highest level of E6 and E7 expression. Additionally, when lens cells from neonatal transgenic animals were placed in tissue culture, immortalized cell populations grew out and acquired a tumorigenic phenotype with continuous passage. These observations indicate that genetic changes in addition to the transgenes are likely necessary for tumor formation. These transgenic mice and cell lines provide the basis for further studies into the mechanism of action of E6 and E7 in eliciting the observed pathology and into the genetic alterations required for HPV-16-associated tumor progression.
Cellular growth and differentiation must be precisely regulated in order to promote normal development and to maintain tissue homeostasis. This regulation is achieved through responses by the cell to intracellular and extracellular growth signals. Studies on retroviruses led to the identification of a class of genes, oncogenes, that promote cell growth and tumorigenesis. More recently, genetic analysis of human cancers led to the identification of a second class of genes, tumor suppressor genes, which suppress cell growth and tumorigenicity. These two classes of genes are believed to be important in mediating the cell's response to growth signals. Thus, disturbances in the balanced response to these signals can result from alteration of oncogenes or tumor suppressor genes, causing abnormal cell growth and differentiation and contributing to carcinogenesis. Such imbalances have been experimentally induced in vivo through the generation of transgenic mice (for reviews, see references 1 and 18) . In several such studies, aberrant expression of cellular proto-oncogenes or expression of mutationally activated proto-oncogenes such as those originally isolated from retroviruses results in abnormal cell proliferation and in tumorigenesis. Oncoproteins from the DNA tumor viruses, simian virus 40 (SV40), polyomavirus, and bovine papillomavirus also have been shown to be inducers of carcinogenesis in transgenic mice. Early events in the course of disease in these mice often involve the inhibition of cellular differentiation and concomitant induction of abnormal cellular proliferation. In this transgenic mouse study we describe the in vivo properties of E6 and E7, the two oncoproteins encoded by human papillomaviruses (HPV) that have been implicated in cervical cancer (for a review, see reference 63) .
The E6 and E7 gene products belong to a family of and differentiation. Rb protein, whose genetic disruption is a hallmark of retinoblastoma, is a nuclear protein whose phosphorylation state and ability to associate with a cellular transcription factor, E2F, appear to be regulated during the cell cycle (for a review, see reference 55) . The expression of Rb and the phosphorylation state of the Rb protein are found to be altered during cellular differentiation (6, 57) . These observations have raised the possibility that Rb protein is an important modulator of cell cycle and cell differentiation. It is also thought that p53 is a regulator of cell cycle and/or cell differentiation (see reference 11 and references therein). This protein has recently been identified to be a DNA sequencespecific transcriptional transactivator (25) , and inactivation of this activity correlates with cellular transformation (62) . In mice, disruption of both alleles of the p53 gene did not lead to any apparent developmental defects, although these mice, as adults, did develop tumors with rapidity (11) . Targeted expression of the E6 and E7 proteins in transgenic mice, given their capacity to inactivate p53 and Rb function, could provide a powerful means to address the function of these tumor suppressor genes in cell growth and differentiation and in tumorigenesis.
To define in vivo the biological activities of E6 and E7, we have generated transgenic mice in which we have directed expression of these viral genes to the mouse ocular lens. The lens is an epithelial tissue which undergoes a well-characterized two-stage process of differentiation during embryogenesis (50) . Like the epidermis, which is the natural target tissue for the papillomaviruses, the lens is composed of a single layer of undifferentiated cells, with the remaining layers consisting of cells in various stages of differentiation. Cells in a restricted region of the undifferentiated layer of the lens have the capacity to proliferate throughout life, thereby renewing the population of cells which then undergo differentiation. Expression of a transgene can be targeted to the lens by using the lens-specific acA crystallin promoter (43) .
Because the aA crystallin promoter is active in the lens from early in its embryonic development through adulthood, the long-term effects of the transgene on epithelial cell growth, differentiation, and tumorigenesis can be assessed. This approach has been previously used to study the tumorigenic capacities of oncogenes from other DNA tumor viruses (16, 35) . Targeting For microinjection, the 1.45-kb fragment, which contains the promoter, HPV-16 E6 and E7 genes, and SV40 polyadenylation signals, was isolated by digestion with XmaI and SalI restriction enzymes, which cleave once each within the pUC18 polylinker, and purified by agarose gel electrophoresis as described previously (16) . The purified DNA fragment was microinjected into the male pronuclei of one-cell fertilized embryos (FVB/N x FVB/N) as described (16, 20) by the University of Wisconsin Biotechnology Center's Transgenic Mouse Facility. The transgene was detected by Southern blot analyses of genomic DNA from tail biopsies of 3-weekold mice (16) . The radiolabeled HPV-16 E6 and E7 DNA probe was made by using the random primed labeling method. The 800-bp E6 and E7 DNA used as probe was produced by PCR amplification of sequences from the fulllength clone of HPV-16 DNA, by using oligo 1 and oligo 4 Southern blot analyses also showed that in each lineage the transgenes were integrated in a single genomic site in tandem head-to-tail arrangements and that genotypes of progeny mice were indistinguishable from those of their respective founders.
All three transgenic founder mice exhibited the overt lens defects of bilateral microphthalmia and cataracts (Fig. 1B ).
These pathological traits were inherited in a genetically dominant manner in all transgenic progeny. Cataracts were macroscopically visible from day 16.5 in embryogenesis onward and throughout the adult life of the animal. These defects appeared to be mouse strain independent; microphthalmia and cataractous phenotypes were stably inherited when the aAHPV-16E6/E7 Expression of E6 and E7 in transgenic mouse tissues. We predicted that both E6-and E7-specific mRNAs would be transcribed from the oA crystallin promoter in these transgenic mice through differential splicing, similar to their expression from the endogenous HPV-16 P97 promoter (54) . To determine if the observed lens phenotype was correlated with expression of E6 and/or E7 mRNAs, RNA isolated from neonatal and adult lenses was subjected to RNA PCR analysis and then to Southern hybridization to an HPV-16 E6-and E7-specific DNA probe. The strategy and predicted PCR products are outlined in Fig. 2A . Using oligonucleotide 2 for reverse transcription and oligonucleotides 2 and aoPl for subsequent PCR amplification, three amplification products would be predicted; a 523-bp product derived from the unspliced E6-specific transcript, and 348-and 233-bp products derived from the E6*^E7 and E6**^E7 spliced transcripts, respectively. The Southern blot in Fig. 2B indicates that all three predicted amplification products were generated from lens RNA from both neonates and adults in all three transgenic lineages. As occurs in HPV-16-positive human cervical neoplasms, the level of the E6**^E7 transcripts was low in the lens tissue. Generation of these products was sensitive to pretreatment with RNase A and resistant to pretreatment with DNase I, indicating that they arose from mRNA and not contaminating genomic DNA. These transgene specific products were absent in nontransgenic lens RNA samples. Thus, both E6-and E7-specific transcripts are present in the lens at both neonatal and adult stages.
To compare the E6-and E7-specific RNA levels between RNAs isolated from the indicated tissues were subjected to RNA PCR, as described, by using oligonucleotide primers specific for mouse urokinase or mouse aA crystallin, as controls, and HPV-16 E6 and E7. For analysis of E6 and E7, oligo 2 was used for reverse transcription, and oligonucleotides aPl and 2 were used for PCR amplification. PCR products were electrophoresed on 2% agarose gels and stained with ethidium bromide. in two sequential stages, primary and secondary fiber cell differentiation, and results in the formation of a dense, highly ordered tissue. Primary fiber cell differentiation, which ultimately forms the nucleus of the lens, occurs around days 11.5 to 13.5 of embryogenesis. Secondary fiber cell differentiation, which forms the cortex, begins at the conclusion of primary differentiation. This phase of lens fiber cell differentiation proceeds rapidly through the later stages of embryogenesis and early postnatal life and continues, albeit at a diminished rate, as the animal ages. Both primary and secondary fiber cell differentiation are characterized by the onset of mitotic senescence, elongation of cells (in the posterior of the lens vesicle for primary fiber cell differentiation and equatorial epithelia for secondary fiber cell differentiation), expression of differentiation-specific crystallin genes, and the loss of cellular organelles, including the nucleus. This differentiation process in the lens results is a multilayered architecture, in which fiber cells make up the majority of the lens mass, each cell stretching from the posterior to anterior of the tissue and tightly packed into the interior of the lens, with a single layer of undifferentiated epithelial cells along the anterior surface. These features are evident in histological sections of nontransgenic FVB/N lenses taken from day 16.5 embryos (Fig.  3A) and neonates (Fig. 3C) .
The histological features of a AHPV-16E6/E7 mouse lenses are strikingly different from those of the nontransgenic lens. This difference was evident in both day 16.5 embryos (Fig.  3B) and neonates (Fig. 3D) . Grossly, the transgenic mouse lenses appeared disorganized and dysplastic. In place of terminally differentiated lens fiber cells that are characterized by elongated, enucleated morphology, the interior of the transgenic lenses contained numerous small, rounded, nucleated cells, especially in the posterior region ( Fig. 3B and D) . Also present were cavities in the equatorial regions where the lumen of the lens vesicle had not been filled and large areas of sclerosis and mineralization in the lens nucleus (Fig. 3D ). Higher-magnification views of the posterior (Fig. 3E ) and equatorial and anterior (Fig. 3F) regions of the neonatal transgenic lens illustrate the presence of mitotically active cells, the absence of cellular elongation, and a thickening of the anterior epithelium. In contrast, the only region of mitotic activity in a normal lens at this time in development is within a portion (proliferation compartment) of the equatorial epithelium (37) . Abnormal presence of nucleated cells within the body of the lens and the absence of cell elongation was also evident in the day 16.5 embryonic transgenic lens (Fig. 3B) . By immunohistochemical analyses, the differentiation-specific , and -y crystallins were found expressed in the morphologically undifferentiated lens cells within these transgenic lenses (data not shown). This indicates that there was an uncoupling in the regulation of crystallin gene expression from morphological differentiation, as noted previously for transgenic mice expressing other DNA tumor virus oncogenes, SV40 T antigens (35) and polyoma large T antigen (17) . The histology of line 19 neonatal lens was similar to that seen for line 4 and line 18, except that the hyperplasia was more extensive, as evidenced by a higher apparent mitotic index (data not shown).
These histological features of the cLAHPV-16E6/E7 lens indicate that the transgenic lens cells have failed to undergo the normal program of primary and secondary fiber cell differentiation. In place of terminal differentiation there is evidence for abnormal proliferation. These abnormalities in the regulation of lens cell proliferation and in morphological differentiation are likely to be responsible for the cataractous appearance of the embryonic and neonatal transgenic lens.
Furthermore, the impairment of primary fiber cell differentiation indicates that onset of E6 and E7 expression occurs prior to or concurrent with the onset of primary fiber cell differentiation (around day 11.5 in embryogenesis), as predicted from studies describing the onset of a crystallin expression in the developing mouse lens (50) and from previous transgenic studies with the otA crystallin promoter (42, 43) .
Tumorigenic progression of aAHPV-16E6/E7 lens cells in vivo. The histology of the lens in adult line 4 and line 19 mice was examined to determine whether the hyperproliferative state observed in the neonatal lenses continued into adult life and whether this hyperplasia led to tumor formation. At 1 month of age, the transgenic mice displayed a microphthalmic phenotype (Fig. 1B) . Histological analysis indicated a continued absence of elongated fiber cells and the presence of vacuolated cells as well as areas of sclerosis (data not shown). Also found in the interior of the lens were pockets of undifferentiated epithelial cells arising from the equatorial regions. There was a continued presence of mitotically active cells, though at a much reduced level compared with the high level of mitotic activity seen in the neonatal lens sections. The reduced level of cell proliferation combined with the continued absence of normal lens fiber cell differentiation results in the observed microphthalmia. At 6 months of age the aAHPV-16E6/E7 transgenic lens histology was similar to that seen at 1 month of age (data not shown). Figure 4A shows a lens from a line 19 homozygous mouse at 8 months of age, representative of lens histology from line 4 and approximately half of line 19 mouse eyes at 6 to 8 months of age. The lens is very small and irregularly shaped. The center is highly schlerotic, whereas along the periphery, small, rounded, and nucleated lens cells line a highly thickened capsule. These cells were found to express transgene RNA by in situ hybridization (data not shown), confirming the RNA PCR data described in the legend to Fig. 2B . The most pronounced features of these older transgenic lenses are the presence of large amounts of capsule material which is normally synthesized and secreted by lens cells at comparatively much lower levels (50) and the presence of lens cells embedded within this extracellular material (Fig. 4B) . Occasionally there are found mitotically active cells, especially in the posterior region. There is a continued absence of fiber cell elongation. These unusual histological features demonstrate that the cells in adult aAHPV-16E6/E7 transgenic lenses retain their proliferative capacity, but at much reduced frequency compared with that observed in embryos and neonates, and continue to be impaired in their abilities to differentiate.
As indicated above, lens tumors developed in greater than 40% of line 19 mice. Shown in Fig. 4D is a histological section of an eye tumor from an 8-month-old line 19 homozygous mouse, representative of lens tumors seen to date in this line. This section reveals a large mass of proliferating, neoplastic lens cells which has grown outside the broken lens capsule and completely filled the eye. Histologically, the tumor cells appear moderately differentiated and were verified to be lenticular in origin on the basis of ax crystallin-positive immunofluorescence and immunoblot analyses (data not shown). Some cells are multinucleated. There is thickening of the corneal stroma, and in some places the corneal epithelium appears broken, with tumor cells found outside the cornea proper. Neutrophils are present in the corneal stroma as well as in the tumor mass, consistent with there being an inflammatory response. The lens tumor is locally invasive, destroying internal ocular structures such as retina, iris, and ciliary muscle and bodies and breaking into the outermost ocular structures, the cornea at the anterior (Fig. 4E) , and the sclera 11 ,um for panels C and D, and 3 pum for panels E and F. c, lens capsule; e, epithelial cell; f, fiber cell; n, cell nucleus; r, retina; arrowhead, mitosis. In all panels, the anterior of the lens is oriented at the top of the panel.
at the posterior (Fig. 4F) . Whereas the normal lens is an avascular tissue, the tumor mass is infiltrated by numerous blood vessels, indicative of angiogenesis (Fig. 4D to F 19 acAHPV-16E6/E7 transgenic mice. All eyes were embedded in methacrylate, sectioned, and stained with hematoxylin and eosin. Representative sections are shown from an eye without a tumor from an 8-month-old line 19 homozygote (A), the anterior region of the lens shown in panel A (B), the anterior region of a lens from a 6-month-old nontransgenic FVB/N mouse (C); eye containing a tumor from an 8-month-old line 19 homozygote (D); and higher magnification of the anterior (E) and posterior (F) regions of the tumor. Bar, 44 ,um for panels A and D; and 3 p.m for panels B, C, E, and F. c, lens capsule; ce, corneal epithelium; cs, corneal stroma; d, Descemets membrane; e, epithelial cells; n, neutrophils; r, retina; rb, erythrocytes; s, sclera; t, tumor cells; arrowhead, mitosis. In all panels, the anterior of the eye is oriented at the top of the panel.
derived from tumor tissue expressed the E6 and E7 transvitro. Hyperplasia is thought to be a prerequisite for tumorgenes (data not shown). Tumor tissue and the derived cell igenic progression, allowing for the accumulation of neceslines were tumorigenic upon transplantation into syngeneic sary secondary genetic changes that provide the cell a neonates (data not shown).
selective growth advantage. In this study, there appeared to Tumorigenic progression of aAHPV-16E6/E7 lens cells in be a correlation between high levels of E6 and E7 mRNA, Fig.  4B ), despite a continued expression of the E6 and E7 genes (Fig. 2B) . Prior studies had suggested that the adult ocular environment has the capacity to suppress lens cell proliferation (17 To assess whether the above transformation property correlated with tumorigenicity, aAHPV-16E6/E7 lens cells from various passages and from isolated soft agar clones were injected into neonatal syngeneic mice (Table 2) . Cells from early (passage 2, 4, and 6) aAHPV-16E6/E7 lens cultures had no capacity to form tumors in mice, while high-passage (passage 24 and 36) cells that possessed the capacity to form soft agar colonies efficiently were also efficient at producing tumors, with palpable tumors arising within 3 weeks of injection. Cells from passage 15 and 17 that showed very low levels of colony formation in soft agar had a limited capacity to form tumors in mice, with reduced efficiency (2 of 12 mice injected) and longer latency (6 versus 3 weeks). Clones isolated from soft agar yielded tumors in proportion to their efficiency of cloning in agar; specifically, agar clone 10, which had a relatively low level of colony growth compared with the other clones, was inefficient at forming tumors. Tumors were directly transplantable (Table  2) , and cells isolated from primary tumors, when cultured and then reinjected into mice, were also tumorigenic (data not shown). Thus, whereas line 4 lenses did not develop tumors spontaneously in vivo, line 4 lens cell populations could acquire the ability to form colonies efficiently in soft agar and to form tumors in syngeneic animals when permitted to proliferate outside the lens environment. These results are consistent with the proposal that the lens environment is (Table 1) and to form aggressively growing tumors when injected into syngeneic mice (Table 2) . We conclude that the absence of spontaneously occurring tumors in line 4 (and in line 18) mice results at least in part from the inability of line 4 lens cells to overcome negative growth regulatory signals present in the adult in vivo lens environment rather than from an inherent inability for these lens cells to proliferate or progress per se. Consistent with this conclusion is the prior observation that lens cells which are phenotypically immortalized by polyoma large T antigen are nevertheless responsive to the growth inhibitory effects of bFGF and insulin (17) , growth factors that are believed to be regulators of lens cell differentiation (3, 5) . That line 19 cells possess the capacity to progress in vivo may indicate that sufficient levels of E6 and E7 can overcome the suppression of lens cell proliferation by environmental factors.
The long latency in tumor formation in the line 19 aAHPV-16E6/E7 mice is consistent with the need for the accumulation of additional genetic changes in the lens cell during progression. This late adult onset tumorigenesis is comparable to the temporal appearance of testicular tumors in adult transgenic mice expressing HPV-16 E6 and E7 genes from the mouse mammary tumor virus transcriptional control elements (27) , though in the latter study there was no correlation between viral oncogene expression and any premalignant pathology. Similar to the lens tumors described in our study, the testicular tumors appeared at approximately 6 to 8 months of age, were vascularized and locally invasive, but were not metastatic, on the basis of gross examination, at the time the animals were sacrificed. The efficient induction of tumors in aA1HPV-16E6/E7 mice and the generation of a series of cell populations in tissue culture that have acquired a tumorigenic potential with cell passage should provide us the means to identify those genetic changes which are most frequently associated with progression, as has been supplied previously by transgenic mice expressing the bovine papillomavirus transforming gene E5 (24, 33) .
Comparison of E6 and E7 to other viral oncogenes expressed in the transgenic mouse lens. The lens has been utilized as a target for the expression of several viral oncogenes through the use of the aA crystallin promoter, providing a basis for comparing their in vivo activities. Our data indicate that the HPV-16 E6 and E7 genes display an intermediate potential for altering epithelial cell growth and differentiation and in inducing tumor formation. By far the most active oncogenes tested to date in the lens are the SV40 T antigens. Expression of the SV40 early region in the lens resulted in efficient and rapid onset of tumors apparent in many lines at birth (35) . One SV40 transgenic line, aT2, however, displayed latencies of up to 4 months before tumor formation was detected, and this latency correlated with both the time of onset and level of expression of the SV40 transgenes (42) .
The ocular pathology of the a-AHPV-16E6/E7 line 19 mice resembles that observed for the aLT2 line. The polyomavirus large T antigen gene (PyLT) did not induce tumor formation in the mouse lens, though these lenses failed to develop normally because of impaired fiber cell differentiation (16) . In the cxAPyLT neonatal mouse lens, the abundance of proliferating cells was much lower than in the aAHPV-16E6/E7 mouse lens, which in turn was lower than in the aoTl (rapid tumor onset line) mouse lens. Thus, the degree to which the viral oncogenes disrupted normal epithelial cell growth and differentiation correlated with the propensity for tumor formation.
The differences in the biological activities of these viral oncoproteins in the transgenic mouse lines may relate to differences in their biochemical properties, specifically, their capacity to interact with cellular tumor suppressor gene products. The SV40 large T antigen is known to associate with both p53 (31, 34) and Rb (10), the same tumor suppressor gene products targeted by the HPV-16 E6 and E7 proteins (13, 60) . In both cases, transgene expression resulted in tumor formation. In contrast, the polyomavirus large T antigen only binds to Rb (12) , and its expression in the lens did not correlate with tumorigenesis. A simple interpretation is that the inactivation of p53 may contribute to tumorigenesis in the lens, consistent with the high incidence of p53 mutational inactivation seen in many cancers (32) . Other factors, however, may contribute to the differences observed among these transgenic lines, including (i) the expression of small t antigen in SV40 transgenic mice (8, 42) , (ii) the timing of expression of the transgene during lens development (42) , and (iii) the levels of expression of the transgenes (42; this study).
E6 and E7 as probes for understanding growth control during tissue development. The primary biological effect of E6 and E7 in the transgenic lens was the efficient (100% penetrance in all three lines of transgenic mice) impairment of cell differentiation and induction of proliferation, histological features seen in HPV-16-infected tissue and associated neoplasias. These transgenic studies may therefore provide a good model system to study the mechanism of J. VIROL. (45) . Consistent with these preliminary data are recent studies in which a null mutation of p53 was generated in the mouse germline via gene targeting. These p53-deficient mice develop normally but are predisposed to multiple neoplasms as adults (11) , again suggesting that p53 function is dispensible for normal embryonic development.
